2021. Lipoprotein(a) as an Unmodifiable Risk Marker in a Modifiable Risk World: Testing, Interpretation and Communication. Journal of Heart and Cardiovascular Science. 2, 1 (Nov. 2021), 14–19. DOI:https://doi.org/10.5281/zenodo.22305492.